
Download Complimentary Report Summary
Cutting Edge Information's latest study delves into the challenges facing pharmaceutical portfolio management teams. As one of the most important components to strategic planning, portfolio management is often left neglected or under-resourced. As many as 82% of pharmaceutical companies believe that their portfolio management successes have been adequate at best. Two-thirds of companies believe that their portfolio management function is lacking resources.
It is no surprise then that many companies struggle with how they will strategically invest in their portfolio products, how to coordinate activities and when to make the decision to cease development in underperforming projects.
Among the many findings that analysts discovered through this research, several strategies and industry trends emerged as more significant, including:
Cutting Edge Information developed this research to guide pharmaceutical and biotechnology companies' portfolio management teams. The study includes benchmark data to help portfolio management teams gain adequate resources and understand how best to allocate brand team budgets. The report makes its case with metrics, tools and techniques for managing portfolio planning in these key areas:
Call Adam Bianchi at 919-433-0202 to get your own copy of "Pharmaceutical Portfolio Management Strategy" today.